Summary

Eligibility
for people ages up to 20 years (full criteria)
Location
at UCLA UCSF
Dates
study started
completion around

Description

Summary

ASCEND researchers are partnering with families of children who receive extracorporeal membrane oxygenation (ECMO) after a sudden failure of breathing named pediatric acute respiratory distress syndrome (PARDS). ECMO is a life support technology that uses an artificial lung outside of the body to do the lung's work. ASCEND has two objectives.

The first objective is to learn more about children's abilities and quality of life among ECMO-supported children in the year after they leave the pediatric intensive care unit. The second objective is to compare short and long-term patient outcomes in two groups of children: one group managed with a mechanical ventilation protocol that reserves the use of extracorporeal membrane oxygenation (ECMO) until protocol failure to another group supported on ECMO per usual care.

Details

Keywords

Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation, ARDS, ECMO, Extracorporeal Life Support, ECLS, Pediatric, Quality of Life, Functional Status, Respiratory Distress Syndrome, Newborn Respiratory Distress Syndrome, Acute Lung Injury, ECMO support, PROSpect protocolized therapies

Eligibility

Locations

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of Michigan
ID
NCT05388708
Study Type
Observational
Participants
Expecting 550 study participants
Last Updated